Drug Profile
RTU 1096
Alternative Names: RTU-1096; VAP-1 inhibitors - MallinckrodtLatest Information Update: 21 Feb 2018
Price :
$50
*
At a glance
- Originator R-Tech Ueno
- Developer Hokkaido University; Kyushu University; Sucampo Pharmaceuticals
- Class Anti-inflammatories; Antipsoriatics; Skin disorder therapies
- Mechanism of Action AOC3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atopic dermatitis; Cataracts; Contact dermatitis; Diabetic macular oedema; Diabetic neuropathies; Diabetic retinopathy; Psoriasis